Osaic Holdings’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,857
| Closed | -$42.4K | – | 8004 |
|
|
2025
Q2 | $42.4K | Sell |
2,857
-191
| -6% | -$950 | ﹤0.01% | 5168 |
|
|
2025
Q1 | $15.1K | Buy |
3,048
+162
| +6% | +$515 | ﹤0.01% | 5551 |
|
|
2024
Q4 | $8.48K | Buy |
2,886
+44
| +2% | +$180 | ﹤0.01% | 5892 |
|
|
2024
Q3 | $13.4K | Sell |
2,842
-488
| -15% | -$2.2K | ﹤0.01% | 5627 |
|
|
2024
Q2 | $12.8K | Sell |
3,330
-14,606
| -81% | -$65.9K | ﹤0.01% | 5630 |
|
|
2024
Q1 | $96K | Sell |
17,936
-5,440
| -23% | -$25.6K | ﹤0.01% | 4283 |
|
|
2023
Q4 | $99.8K | Buy |
23,376
+11,986
| +105% | +$36.8K | ﹤0.01% | 4447 |
|
|
2023
Q3 | $44.6K | Buy |
11,390
+6,147
| +117% | +$40.3K | ﹤0.01% | 5069 |
|
|
2023
Q2 | $53K | Sell |
5,243
-18,869
| -78% | -$200K | ﹤0.01% | 4899 |
|
|
2023
Q1 | $246K | Buy |
24,112
+20,671
| +601% | +$236K | ﹤0.01% | 3703 |
|
|
2022
Q4 | $31.2K | Sell |
3,441
-43
| -1% | -$607 | ﹤0.01% | 5264 |
|
|
2022
Q3 | $50K | Sell |
3,484
-285
| -8% | -$4.23K | ﹤0.01% | 4903 |
|
|
2022
Q2 | $50K | Buy |
3,769
+2,812
| +294% | +$38.3K | ﹤0.01% | 4964 |
|
|
2022
Q1 | $16K | Sell |
957
-3,160
| -77% | -$53.6K | ﹤0.01% | 5851 |
|
|
2021
Q4 | $105K | Buy |
+4,117
| New | +$128K | ﹤0.01% | 4562 |
|
Osaic Holdings's TSVT Position: Q3 2025 in Review
Osaic Holdings sold out of 2seventy bio (TSVT) in Q3 2025, closing a stake of 2,857 shares — an estimated $42.4K sold.
Osaic Holdings first reported a position in TSVT in Q4 2021 and held it in 15 quarters. The position peaked at $246K in Q1 2023. 0 funds tracked by Wall St. Rank hold TSVT as of Q3 2025.
- Osaic Holdings reported no remaining 2seventy bio position as of Q3 2025 after selling out during the quarter.
- Osaic Holdings sold 2,857 2seventy bio shares in Q3 2025, an estimated $42.4K.
- Osaic Holdings first reported a position in 2seventy bio in Q4 2021 and held it in 15 quarters.
- Osaic Holdings's 2seventy bio position peaked at $246K in Q1 2023.
- 0 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2025.
Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.